HC Wainwright & Co. Reiterates Buy on Satellos Bioscience, Maintains $18 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 91.4%

Neg 0% Neu 91.4% Pos 0%

HC Wainwright & Co. analyst Arthur He reiterates Satellos Bioscience (NASDAQ:MSLE) with a Buy and maintains $18 price target.